REPLIGEN ($RGEN) posted quarterly earnings results for Q1 2026 on Tuesday, May 5th. The company reported earnings of $0.48 per share, beating estimates of $0.39 by $0.09. The company also reported revenue of $194,260,000, missing estimates of $196,124,580 by $-1,864,580.
You can see Quiver Quantitative's $RGEN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
REPLIGEN Insider Trading Activity
REPLIGEN insiders have traded $RGEN stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $RGEN stock by insiders over the last 6 months:
- ANTHONY HUNT has made 0 purchases and 12 sales selling 45,000 shares for an estimated $7,014,218.
- OLIVIER LOEILLOT (Chief Executive Officer) has made 0 purchases and 2 sales selling 10,873 shares for an estimated $1,733,450.
- JAMES BYLUND (Chief Operating Officer) sold 2,191 shares for an estimated $331,301
- KAREN A DAWES sold 275 shares for an estimated $44,275
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
REPLIGEN Hedge Fund Activity
We have seen 211 institutional investors add shares of REPLIGEN stock to their portfolio, and 235 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WASATCH ADVISORS LP added 1,243,531 shares (+inf%) to their portfolio in Q1 2026, for an estimated $146,512,822
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 1,215,527 shares (+inf%) to their portfolio in Q4 2025, for an estimated $199,176,254
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,091,683 shares (+31.1%) to their portfolio in Q4 2025, for an estimated $178,883,176
- RTW INVESTMENTS, LP added 1,064,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $174,347,040
- FRANKLIN RESOURCES INC added 677,146 shares (+159.6%) to their portfolio in Q4 2025, for an estimated $110,957,143
- BALYASNY ASSET MANAGEMENT L.P. removed 652,186 shares (-85.0%) from their portfolio in Q4 2025, for an estimated $106,867,197
- FRED ALGER MANAGEMENT, LLC added 553,105 shares (+154.3%) to their portfolio in Q4 2025, for an estimated $90,631,785
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
REPLIGEN Price Targets
Multiple analysts have issued price targets for $RGEN recently. We have seen 7 analysts offer price targets for $RGEN in the last 6 months, with a median target of $160.0.
Here are some recent targets:
- Kyle Mikson from Canaccord Genuity set a target price of $145.0 on 04/20/2026
- Natalya Davies from Roth Capital set a target price of $160.0 on 04/17/2026
- Luke Sergott from Barclays set a target price of $145.0 on 04/14/2026
- Daniel Markowitz from Evercore ISI Group set a target price of $140.0 on 04/06/2026
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $208.0 on 03/23/2026
- Brandon Couillard from Wells Fargo set a target price of $180.0 on 02/25/2026
- Dan Leonard from UBS set a target price of $195.0 on 02/25/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
